Results 21 to 30 of about 144,736 (256)
Vaccines, 2022 In the light of the lack of authorized COVID-19 vaccines adapted to the Omicron variant lineage, the administration of the first and second booster dose is recommended.
Dorota Zarębska-Michaluk +4 more
doaj +1 more source
Vaccines, 2022 Background: Several countries are implementing COVID-19 booster vaccination campaigns. The objective of this study was to model the impact of different primary and booster vaccination strategies.
Clément R. Massonnaud +3 more
doaj +1 more source
COVID Arm After Moderna Booster in Healthcare Worker: A Case Report
Acta Medica Indonesiana, 2021 SARS CoV-2 virus has infected more than 200 million people worldwide and more than 4.4 million in Indonesia. The vaccination program has become one of the solutions launched by many countries globally, including Indonesia, to reduce the transmission rate
Anshari Saifuddin +5 more
doaj
Frontiers in Immunology, 2022 Data on humoral and cellular responses to BNT162b2 as a booster dose, following two doses of ChAdOx1 nCov-19 vaccine, have seldom been reported. The aim of this study was to assess the positivity rates of three representative antibody assays targeting ...
Seri Jeong +7 more
doaj +1 more source
A randomised controlled trial and cost-effectiveness evaluation of "booster" interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods [PDF]
, 2010 Background: Systematic reviews have identified a range of brief interventions which increase physical activity in previously sedentary people. There is an absence of evidence about whether follow up beyond three months can maintain long term physical ...
Daniel Hind +62 more
core +3 more sources
Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium
, 2023 Background To tackle waning protection against severe COVID-19 infection, booster doses of the COVID-19 vaccines were recommended among individuals who received their primary course.
L. Catteau +7 more
core +1 more source
Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial [PDF]
, 2014 BACKGROUND: In a previous UK multi-center randomized study 278 children received three doses of 7-valent (PCV-7) or 13-valent (PCV-13) pneumococcal conjugate vaccine at 2, 4 and 12 months of age.
Trück, J +50 more
core +1 more source
PHS Booster - Advertisements [PDF]
, 1930 Digital reproduction of microfilmed fashion advertisements from 1930-1949 that appeared in The Booster, a publication printed out of Pittsburg High ...
The Booster,
core +1 more source
, 1930 Digital reproduction of microfilmed articles and Nellie\u27s Nook sections of The Booster, a Pittsburg High School publication, from the years 1930-1949.https://digitalcommons.pittstate.edu/nellydonpubs/1002/thumbnail ...
The Booster,
core +1 more source
A randomised controlled trial and cost-effectiveness evaluation of 'booster' interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods [PDF]
, 2014 Background: More evidence is needed on the potential role of 'booster' interventions in the maintenance of increases in physical activity levels after a brief intervention in relatively sedentary populations.
Daniel Hind +54 more
core +1 more source